viernes, 11 de noviembre de 2011
Monoclonal antibodies against flu
Influenza and related medical complications result in an estimated number of 500000 annual deaths worldwide. While flu affects individuals of all ages, elderly above the age of 65 constitute approximately 90% of flu-related deaths. Scientists at Crucell and the Scripps Research Institute have discovered monoclonal antibodies that neutralize a broad range of flu viruses. The unique property of these antibodies depends on their ability to bind to a conserved region on
Suscribirse a:
Enviar comentarios (Atom)
Hey guys,
ResponderEliminarThis is the perfect blog for anyone who wants to know about this topic. Monoclonal antibodies are a key component of the adaptive immune response, playing a central role in both in the recognition of foreign antigens and the stimulation of an immune response to them...
Drug Discovery